Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Neuroone Medical Technologies (NMTC) Net Margin (2020 - 2025)

Neuroone Medical Technologies' Net Margin history spans 12 years, with the latest figure at 49.71% for Q4 2025.

  • For Q4 2025, Net Margin fell 10424.0% year-over-year to 49.71%; the TTM value through Dec 2025 reached 78.34%, up 4667.0%, while the annual FY2025 figure was 39.63%, 31711.0% up from the prior year.
  • Net Margin reached 49.71% in Q4 2025 per NMTC's latest filing, up from 59.08% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 54.53% in Q4 2024 to a low of 13124.54% in Q1 2021.
  • Average Net Margin over 5 years is 2945.3%, with a median of 653.18% recorded in 2023.
  • Peak YoY movement for Net Margin: plummeted -557741bps in 2021, then skyrocketed 806028bps in 2023.
  • A 5-year view of Net Margin shows it stood at 8318.94% in 2021, then soared by 82bps to 1512.29% in 2022, then skyrocketed by 77bps to 342.14% in 2023, then soared by 116bps to 54.53% in 2024, then crashed by -191bps to 49.71% in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Net Margin are 49.71% (Q4 2025), 59.08% (Q3 2025), and 88.49% (Q2 2025).